We have shown that the differential densities and spatial distribution of CD8+ and CD163+ cells as described by the FCIS could identify patients with increased DFS or patients who lived longer despite the fact that these were in late tumor stages according to the TNM classification. The gene discussed is CD8A; the disease is neoplasm.